Fig. 1From: Unexpected profile of sphingolipid contents in blood and bone marrow plasma collected from patients diagnosed with acute myeloid leukemiaConcentration of SFO (panel a), SFA (panel b), S1P (panel c) and ceramide (panel d) in blood plasma samples collected from subject included in control group (n = 51) and AML patients (n = 49). The ratio of ceramide to SFO and ceramide to S1P in control and AML blood plasma samples are shown on panel e and f, respectivelyBack to article page